New research shows that 46% of generic drugs from the European Union (EU) critical list of medicines are supplied by just one provider.

The pharmaceutical industry is preparing for ‘major disruptions’ following US President Donald Trump’s announcement on ...

FibroGen today announced the sale of its China subsidiary to UK pharma major AstraZeneca for around $160 million, with the ...

South Korea-based Celltrion today announced that the European Commission (EC) has granted marketing authorization for three ...

CSPC Megalith Biopharmaceutical has entered into a license agreement with Radiance Biopharma for the development and ...

Japanese drugmaker Chugai Pharmaceutical today announced gaining regulatory approval from the Ministry of Health, Labor and ...

Sweden’s BioArctic today revealed that the US Federal Trade Commission (FTC) has cleared the proposed deal with Bristol Myers ...

Hong Kong-based Ascletis Pharma announced today positive interim results from the first two cohorts of its randomized, double ...

US CNS specialist Supernus Pharmaceuticals has announced that its Phase IIb study of SPN-820 in adults with ...

Eleva, a German company developing difficult-to-produce biologics based on a breakthrough moss-based platform, has announced the appointment of Martin Bauer as its chief medical officer (CMO).

Swiss drug developer Basilea Pharmaceutica yesterday announced its results for the financial year ended December 31, 2024.

The International Generic and Biosimilar Medicines Association (IGBA), in line with its goals of promoting the widest possible access to safe, effective, and quality-assured medicines and of promoting ...